Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. Its structure, featuring a 6-bromopyridin-2-yl acetamido group linked to a Boc-protected ethylamine, allows for selective modification in drug design. The Boc (tert-butoxycarbonyl) protection of the amino group enables controlled regioselective reactions, reducing side products and improving yield. This makes it valuable in creating bioactive molecules with improved stability and binding affinity. Commonly employed in medicinal chemistry for constructing complex heterocyclic systems found in targeted therapies.